e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

22.72 -0.93 (-3.93%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about uniQure N.V. - Ordinary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Nasdaq Turns Lower; Crude Oil Rises Over 1% ↗

August 08, 2022

U.S. stocks pared gains toward the end of trading, with the S&P 500 and the Nasdaq turning lower on Monday.

Via Benzinga

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

Why UniQure Shares Are Plummeting Today? ↗

August 08, 2022

Via Benzinga

UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial ↗

June 23, 2022

Via Benzinga

Dow Jumps Over 150 Points; Karuna Therapeutics Shares Spike Higher ↗

August 08, 2022

U.S. stocks traded higher this morning, following the release of strong jobs data on Friday.

Via Benzinga

Why U.S. Stocks Are Trading Higher; Tyson Foods Earnings Miss Views ↗

August 08, 2022

U.S. stocks traded higher this morning, following the release of strong jobs data on Friday.

Via Benzinga

Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8% ↗

July 11, 2022

Among its other key ratings, Amsterdam-based gene therapy company Uniqure stock also has a 92 Composite Rating.

Via Investor's Business Daily

Mizuho Comments On UniQure's Upcoming Low-Dose Huntington's Gene Therapy Trial Data ↗

June 13, 2022

The much-awaited one-year data for the entire low-dose cohort for UniQure NV's (NASDAQ: QURE) AMT-130 gene therapy in Huntington's disease is expected at any time.

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

June 13, 2022

The Meaning Behind Value Stocks

Via Benzinga

Analyst Ratings for uniQure ↗

May 24, 2022

Within the last quarter, uniQure (NASDAQ:QURE) has observed the following analyst ratings:

Via Benzinga

Recap: uniQure Q1 Earnings ↗

May 02, 2022

uniQure (NASDAQ:QURE) reported its Q1 earnings results on Monday, May 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

uniQure: Q4 Earnings Insights ↗

February 25, 2022

uniQure (NASDAQ:QURE) reported its Q4 earnings results on Friday, February 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday ↗

June 24, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

April 11, 2022

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022 ↗

March 17, 2022

Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 04, 2022

Good morning, investor! We're almost done with the week but we still need to go over the biggest pre-market stock movers for Friday!

Via InvestorPlace

Revisiting the Biggest Winners and Losers Since the COVID Crash Low ↗

February 16, 2022

A look at how the average stock that’s currently in the S&P 1500 has done since the Covid crash low by sector.

Via Talk Markets

5 Value Stocks To Watch In The Healthcare Sector ↗

February 14, 2022

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

January 24, 2022

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ICPT, AKBA, QURE, BNTX, SAVA)

January 19, 2022

Via AB Newswire

Topics Bonds Stocks

5 Value Stocks In The Healthcare Sector ↗

December 27, 2021

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 ↗

December 17, 2021

Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ:

Via Benzinga

58 Biggest Movers From Yesterday ↗

December 17, 2021

Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Down 2.5%; Calliditas Therapeutics Shares Spike Higher ↗

December 16, 2021

Toward the end of trading Thursday, the Dow traded up 0.05% to 35,946.32 while the NASDAQ fell 2.5% to 15,179.38. The S&P also fell, dropping 0.80% to 4,672.38. The U.S. has...

Via Benzinga

UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial ↗

December 16, 2021

UniQure NV (NASDAQ: QURE) announced initial observations on the first four patients enrolled in the lower-dose cohort of Phase 1/2 trial of AMT-130 for Huntington...

Via Benzinga

Mid-Day Market Update: Gold Rises 2%; IronNet Shares Plummet ↗

December 16, 2021

Midway through trading Thursday, the Dow traded up 0.67% to 36,166.39 while the NASDAQ fell 0.63% to 15,467.79. The S&P also rose, gaining 0.20% to 4,719.09. The U.S. has the...

Via Benzinga

31 Stocks Moving In Thursday's Mid-Day Session ↗

December 16, 2021

Gainers Calliditas Therapeutics AB (NASDAQ: CALT) shares climbed 28.7% to $24.13 after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Accenture Beats Q1 Estimates ↗

December 16, 2021

Following the market opening Thursday, the Dow traded up 0.49% to 36,102.31 while the NASDAQ fell 0.68% to 15,460.25. The S&P also rose, gaining 0.08% to 4,713.43. The U.S....

Via Benzinga

CSL Behring, UniQure's Hemophilia B Gene Therapy Hits Primary Endpoint ↗

December 09, 2021

CSL Behring and uniQure N.V.'s (NASDAQ: QURE) etranacogene dezaparvovec, a hemophilia B gene therapy, achieved the pre-specified primary endpoint of non-...

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

November 22, 2021

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy